BOSTON (CBS.MW) -- Shares of Cerus Corp. plummeted Thursday after the biotech firm and partner Baxter International announced they had suspended a late-stage clinical trial of an experimental ...

Cerus Corp. said Thursday it plans to sell 6 million units of stock and warrants for portions of shares to certain investors for about $13.2 million in a registered direct offering.